Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV testing: rationale for changing recommendations.

Robert S Janssen1

  • 1Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (proposed) at Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, USA.

Topics in HIV Medicine : a Publication of the International AIDS Society, USA
|April 5, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A narrative review of immune-mediated adverse events in clinical trials of CpG oligonucleotide toll-like receptor 9 agonists.

Vaccine·2026
Same author

Phase 2, Open-Label, Multicenter Study of Nelitolimod in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naïve Advanced Melanoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Hepatitis B vaccination with HepB-CpG in people living with HIV: a narrative review.

Expert review of vaccines·2025
Same author

Phase 1 trial of an investigational Tdap booster vaccine with CpG 1018 adjuvant compared with Boostrix in healthy adults and adolescents.

Vaccine·2024
Same author

Long-term immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B) compared with HepB-Eng (Engerix-B) in adults with chronic kidney disease.

Vaccine·2023
Same author

Immunogenicity and safety of a booster dose of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) compared with HepB-Eng (Engerix-B®) and HepB-AS04 (Fendrix®) in adults receiving hemodialysis who previously received hepatitis B vaccination and are not seroprotected: Results of a randomized, multicenter phase 3 study.

Human vaccines & immunotherapeutics·2022
Same journal

Occupational postexposure prophylaxis for HIV: The PEPline perspective.

Topics in HIV medicine : a publication of the International AIDS Society, USA·2011
Same journal

Recalcitrant giant molluscum contagiosum in a patient with advanced HIV disease - eradication of disease with paclitaxel.

Topics in HIV medicine : a publication of the International AIDS Society, USA·2011
Same journal

Evaluating and managing cardiovascular disease risk factors in HIV-infected patients.

Topics in HIV medicine : a publication of the International AIDS Society, USA·2011
Same journal

Update of the drug resistance mutations in HIV-1: December 2010.

Topics in HIV medicine : a publication of the International AIDS Society, USA·2011
Same journal

Current issues in the diagnosis and management of tuberculosis and HIV coinfection in the United States.

Topics in HIV medicine : a publication of the International AIDS Society, USA·2010
Same journal

Sexually transmitted infections and HIV: epidemiology and interventions.

Topics in HIV medicine : a publication of the International AIDS Society, USA·2010
See all related articles

Knowing your HIV status through testing is key to prevention. Routine HIV screening in healthcare settings can significantly reduce new infections and improve patient care.

Area of Science:

  • Public Health
  • Infectious Disease Prevention
  • Epidemiology

Background:

  • HIV testing is a crucial strategy for preventing HIV transmission.
  • Knowledge of HIV serostatus reduces high-risk sexual behaviors.
  • Current HIV screening recommendations are being revised.

Purpose of the Study:

  • To summarize revisions to the Centers for Disease Control and Prevention (CDC) HIV screening recommendations.
  • To highlight the importance of expanded HIV screening in healthcare settings.
  • To emphasize the role of routine, voluntary, and opt-out screening.

Main Methods:

  • Summary of a presentation by Robert S. Janssen, MD.
  • Discussion of updated CDC HIV screening guidelines.
  • Reference to a webcast of the original presentation.

Related Experiment Videos

Main Results:

  • Knowledge of HIV serostatus can reduce new infections by over 30%.
  • Rapid HIV testing increases testing accessibility.
  • Routine screening is essential for identifying unaware individuals and reducing transmission.

Conclusions:

  • Expanded routine HIV screening in healthcare settings is recommended.
  • Opt-out screening strategies can increase the number of individuals aware of their HIV status.
  • Early diagnosis and linkage to care are vital for managing HIV infection and preventing further spread.